by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty

Slides:



Advertisements
Similar presentations
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia by Jose Claudio C. Rocha, Cheng Cheng, Wei Liu, Shinji Kishi, Soma Das, Edwin.
Advertisements

CD11b is a therapy resistance– and minimal residual disease–specific marker in precursor B-cell acute lymphoblastic leukemia by Peter Rhein, Rita Mitlohner,
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? by Ching-Hon Pui, Charles G. Mullighan, William E. Evans, and Mary.
ABL1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid Leukemia by Fotis A. Asimakopoulos, Pesach J. Shteper,
Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy  Stefania Aliano, Gabriella Cirmena, Giuseppina.
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification by Estella.
Do HSCs divide asymmetrically?
HS 4160 Critical Scientific Analysis
by Roel Polak, Bob de Rooij, Rob Pieters, and Monique L. den Boer
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
Next-generation leukemia immunotherapy
Fluorescence in situ hybridization confirms the presence of Merkel cell polyomavirus in chronic lymphocytic leukemia cells by Anke Maria Haugg, Ernst-Jan.
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)‏ by Anthony V. Moorman, Susan.
Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,
by Rafael Fonseca, Richard J. Bailey, Gregory J. Ahmann, S
Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing by Sandra Preuner, Renate Kastner,
Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood.
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
CMV: when bad viruses turn good
Fusion genes in cord blood
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
Targeting kinases in CML CLL
Deep mining of the RBC proteome
by Wolfram Springer, Alexander von Ruecker, and Roswitha Dickerhoff
Acute promyelocytic leukemia, microgranular variant
Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,
Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia by Jose Roman-Gomez, Antonio.
by Jayesh Mehta Blood Volume 112(2): July 15, 2008
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic.
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Malignant Progenitors From Patients With Acute Myelogenous Leukemia Are Sensitive to a Diphtheria Toxin–Granulocyte-Macrophage Colony-Stimulating Factor.
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor.
Primary testicular lymphoma
Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia by Manuela.
J. Catalán, K. Autio, E. Kuosma, H. Norppa 
Tumor Necrosis Factor Receptor-Associated Factor 1 Is Overexpressed in Reed-Sternberg Cells of Hodgkin’s Disease and Epstein-Barr Virus-Transformed Lymphoid.
Final Report Of Single-Center Study Of Chemotherapy Plus Dasatinib For The Initial Treatment Of Patients With Philadelphia-Chromosome Positive Acute Lymphoblastic.
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital by Jeffrey E. Rubnitz, Mihaela Onciu, Stanley Pounds,
Patient-Reported Outcomes from a Global Phase 3 Randomized Controlled Trial of Inotuzumab Ozogamicin Versus Standard of Care Chemotherapy for Relapsed/Refractory.
Chronic Myeloid Leukemia
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
by Martin S. Tallman, Donna Neuberg, John M. Bennett, Christopher J
Immunotherapy for acute lymphoblastic leukemia: from famine to feast
A Multicolor FISH Assay Does Not Detect DUP25 in Control Individuals or in Reported Positive Control Cells  Yanina Weiland, Jürgen Kraus, Michael R. Speicher 
Development of an NPM1/MLF1 D-FISH Probe Set for the Detection of t(3;5)(q25;q35) Identified in Patients with Acute Myeloid Leukemia  Umut Aypar, Ryan.
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy by Sara Mastaglio, Eric Wong, Travis.
Representative results of the FISH analyses. 1. 1, patient 1153; 1
MicroRNA Methylation Profile Has Prognosis Impact in Acute Lymphoblastic Leukemia Patients Undergoing Stem Cell Transplantation  Vanesa Martín-Palanco,
Northern blot and Western blot analysis of syndecan-4 expression in TF-1 and HEL cells. Northern blot and Western blot analysis of syndecan-4 expression.
Molecular Cytogenetic Analyses of Immunoglobulin Loci in Nodular Lymphocyte Predominant Hodgkin's Lymphoma Reveal a Recurrent IGH-BCL6 Juxtaposition 
Molecular tracking of leukemogenesis in a triplet pregnancy
Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation  Derek L. Stirewalt,
BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.
Phenotype of rTT.C-specific plasma blasts.
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia by Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison,
Fluorescence In Situ Hybridization Identifies Cryptic t(16;16)(p13;q22) Masked By del(16)(q22) in a Case of AML-M4 Eo  Shakil H. Merchant, Skip Haines,
Changes throughout time in the lineage content of clones regenerated in secondary mice. Changes throughout time in the lineage content of clones regenerated.
Alteration calling accuracy and concordance with reference platforms.
A 22q11.2 Deletion That Excludes UFD1L and CDC45L in a Patient with Conotruncal and Craniofacial Defects  Sulagna C. Saitta, James M. McGrath, Holly Mensch,
Maria Hodges, Catherine Tissot, Kathy Howe, David Grimwade, Paul S
A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
by Dana S. Levy, Jason A. Kahana, and Rakesh Kumar
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib by Chung H. Kok, David T.
Health-Related Quality of Life (HRQoL) of Blinatumomab Versus Standard of Care (SOC) Chemotherapy in Patients with Relaspsed or Refractory Philadelphia.
by Wolfgang Warsch, Christoph Walz, and Veronika Sexl
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
How I treat T-cell acute lymphoblastic leukemia in adults
Cold agglutinin disease
Presentation transcript:

by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty The Juxtaposition of ABL With BCR and Risk for Fusion May Come at the Time of BCR Replication in Late S-Phase by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty Blood Volume 94(3):1137-1138 August 1, 1999 ©1999 by American Society of Hematology

FISH analysis with a probe set for MBCR andABL, in blasts from a patient with recently treated acute lymphoblastic leukemia shown to be Philadelphia-chromosome–negative and BCR/ABL-negative. FISH analysis with a probe set for MBCR andABL, in blasts from a patient with recently treated acute lymphoblastic leukemia shown to be Philadelphia-chromosome–negative and BCR/ABL-negative. The digoxigenin-labeled probe forBCR is detected with anti-dig rhodamine (red), and the biotinylated probe to ABL is detected with fluoreceinated avidin (green). The 3 illustrations represent cells in late S- (A and B) and G2M-phase (C) of the cell cycle. In (A), there are 4 green and 3 red signals with close proximity of BCR/ABL(inset). In (B), there are 4 green and 3 red signals, including a doubling BCR (red) signal which is juxtaposed to ABL(inset). The cell in (C) is at G2M and shows 4 green and 4 red signals with no juxtaposition of BCR and ABL. John Anastasi et al. Blood 1999;94:1137-1138 ©1999 by American Society of Hematology